MYO
Myomo, Inc.·Healthcare
1.00
2.913%(−0.03)
Close PriceLast Updated: — ET
52W L: $0.6052W H: $3.14
MYO NEWS
businesswire.com
May 13
Myomo Appoints Joseph M. Manko to its Board of Directors
BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the appointment of Joseph M. (“Joe”) Manko Jr. as a director effective May 9, 2026, to serve until the 2027 annual meeting of stockholders. With this appointment, Myomo has seven directors. Mr. Manko is an accomplished investor with over 25.
zacks.com
May 12
Here Is Why Bargain Hunters Would Love Fast-paced Mover Myomo (MYO)
Myomo (MYO) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
seekingalpha.com
May 8
Myomo, Inc. (MYO) Q1 2026 Earnings Call Transcript
Myomo, Inc. (MYO) Q1 2026 Earnings Call Transcript
zacks.com
May 7
Myomo, Inc. (MYO) Reports Q1 Loss, Beats Revenue Estimates
Myomo, Inc. (MYO) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to a loss of $0.08 per share a year ago.
businesswire.com
May 7
Myomo Reports First Quarter 2026 Financial and Operating Results
BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three months ended March 31, 2026. “Earlier this year we established four success pillars for 2026, including growing revenue from recurring patient sources, increasing market access, demonstrating operating leverag.
businesswire.com
May 4
Myomo Announces Availability of MyoPro at Ottobock Care Clinics in the U.S.
BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO), a wearable medical robotics company and manufacturer of the MyoPro® powered arm brace, announces expanded access to the MyoPro device through Ottobock Care clinics nationwide. Ottobock Care will offer the MyoPro through its clinics across the country, helping individuals with upper extremity impairment caused by stroke, brachial plexus injury, or other neurological conditions regain function and improve quality of life. “The.
